Benralizumab Associated with Less Use of Oral Glucocorticoids in Severe Asthma (FREE)

By Kelly Young

Edited by David G. Fairchild, MD, MPH, and Jaye Elizabeth Hefner, MD
The investigational monoclonal antibody benralizumab is associated with reduced oral glucocorticoid use in patients with severe asthma, according to a phase 3, industry-funded …

Source: Physician's First Watch current issue - May 22, 2017 Category: Primary Care Source Type: news